David Goodlett is a Professor and Director of the UVIC Genome BC Proteomics Centre in the Department of Biochemistry and Microbiology at the University of Victoria. He holds a BSc and PhD from North Carolina State University (NCSU). His research focuses on host-pathogen interactions, lipid A structure-activity relationships, microbial diagnostics, and proteomics-driven systems biology. Dr. Goodlett leads a lab developing mass spectrometry-based technologies, including lipidomics and MALDI-TOF MS for rapid bacterial identification. Education: BSc, North Carolina State University PhD, North Carolina State University Research Interests: Structural elucidation of lipid A in Gram-negative bacteria for vaccine development Development of mass spectrometry tools (e.g., SAWN, MALDI-TOF) for clinical diagnostics Proteomic profiling of cancer biomarkers and immune response mechanisms Bioinformatics pipelines for cross-linking mass spectrometry (CLMS) Awards & Grants: NIH R01 Grant GM111066-01 (2015) for MS-based bacterial identification Ardgour Symposium Ethos Award (2011) for collaborative research excellence Lab & Collaborations: Led development of the xComb software for cross-linked peptide analysis Partnerships with Deurion for commercializing SAWN technology FiDiPro Finland Distinguished Professorship (2014-2016) for diabetes and ovarian cancer biomarker research Students & Trainees: Current students: Madison Shiyuk, Bo Ren, Linda Nartey, Sophie Culos, Kate McMurray Prior postdocs include Pragya Singh (PhD 2011), Sunhee Jung (PhD 2011), and Scott Heron












